Other

Thereafter

Royalty Pharma Thereafter decreased by 54.5% to $3.13M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ2 2025
Last reportedQ1 2026
Metric ID: other_lessee_operating_lease_liability_to_be_paid_after__06272e

Historical Data

3 periods
 Q2 '25Q3 '25Q1 '26
Value$6.88M$6.88M$3.13M
QoQ Change—+0.0%-54.5%
Range$3.13M – $6.88M

Frequently Asked Questions

What is Royalty Pharma's thereafter?
Royalty Pharma (RPRX) reported thereafter of $3.13M in Q1 2026.